These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

224 related articles for article (PubMed ID: 21694700)

  • 1. Exogenous peptide YY3-36 and Exendin-4 further decrease food intake, whereas octreotide increases food intake in rats after Roux-en-Y gastric bypass.
    Fenske WK; Bueter M; Miras AD; Ghatei MA; Bloom SR; le Roux CW
    Int J Obes (Lond); 2012 Mar; 36(3):379-84. PubMed ID: 21694700
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of exendin-4 alone and with peptide YY(3-36) on food intake and body weight in diet-induced obese rats.
    Reidelberger RD; Haver AC; Apenteng BA; Anders KL; Steenson SM
    Obesity (Silver Spring); 2011 Jan; 19(1):121-7. PubMed ID: 20559304
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Peptide YY and glucagon-like peptide-1 contribute to decreased food intake after Roux-en-Y gastric bypass surgery.
    Svane MS; Jørgensen NB; Bojsen-Møller KN; Dirksen C; Nielsen S; Kristiansen VB; Toräng S; Wewer Albrechtsen NJ; Rehfeld JF; Hartmann B; Madsbad S; Holst JJ
    Int J Obes (Lond); 2016 Nov; 40(11):1699-1706. PubMed ID: 27434221
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Acute peripheral GLP-1 receptor agonism or antagonism does not alter energy expenditure in rats after Roux-en-Y gastric bypass.
    Abegg K; Schiesser M; Lutz TA; Bueter M
    Physiol Behav; 2013 Sep; 121():70-8. PubMed ID: 23562866
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Primary weight loss failure after Roux-en-Y gastric bypass is characterized by impaired gut-hormone mediated regulation of food intake.
    Bojsen-Møller KN; Svane MS; Martinussen C; Dirksen C; Jørgensen NB; Jensen JB; Jensen CZ; Torekov SS; Kristiansen VB; Rehfeld JF; Bork-Jensen J; Grarup N; Hansen T; Hartmann B; Holst JJ; Madsbad S
    Int J Obes (Lond); 2023 Nov; 47(11):1143-1151. PubMed ID: 37653071
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Gut hormones as mediators of appetite and weight loss after Roux-en-Y gastric bypass.
    le Roux CW; Welbourn R; Werling M; Osborne A; Kokkinos A; Laurenius A; Lönroth H; Fändriks L; Ghatei MA; Bloom SR; Olbers T
    Ann Surg; 2007 Nov; 246(5):780-5. PubMed ID: 17968169
    [TBL] [Abstract][Full Text] [Related]  

  • 7. GLP-1 and PYY
    Dischinger U; Corteville C; Otto C; Fassnacht M; Seyfried F; Hankir MK
    Surg Obes Relat Dis; 2019 Sep; 15(9):1483-1492. PubMed ID: 31548004
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Toward a Medical Gastric Bypass: Chronic Feeding Studies With Liraglutide + PYY
    Dischinger U; Hasinger J; Königsrainer M; Corteville C; Otto C; Fassnacht M; Hankir M; Seyfried FJD
    Front Endocrinol (Lausanne); 2020; 11():598843. PubMed ID: 33551994
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Roux-en-Y gastric bypass in rats increases sucrose taste-related motivated behavior independent of pharmacological GLP-1-receptor modulation.
    Mathes CM; Bueter M; Smith KR; Lutz TA; le Roux CW; Spector AC
    Am J Physiol Regul Integr Comp Physiol; 2012 Mar; 302(6):R751-67. PubMed ID: 22170618
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Differential effects of laparoscopic sleeve gastrectomy and laparoscopic gastric bypass on appetite, circulating acyl-ghrelin, peptide YY3-36 and active GLP-1 levels in non-diabetic humans.
    Yousseif A; Emmanuel J; Karra E; Millet Q; Elkalaawy M; Jenkinson AD; Hashemi M; Adamo M; Finer N; Fiennes AG; Withers DJ; Batterham RL
    Obes Surg; 2014 Feb; 24(2):241-52. PubMed ID: 23996294
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparative effects of the long-acting GLP-1 receptor ligands, liraglutide and exendin-4, on food intake and body weight suppression in rats.
    Hayes MR; Kanoski SE; Alhadeff AL; Grill HJ
    Obesity (Silver Spring); 2011 Jul; 19(7):1342-9. PubMed ID: 21415845
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Gut hormone profiles following bariatric surgery favor an anorectic state, facilitate weight loss, and improve metabolic parameters.
    le Roux CW; Aylwin SJ; Batterham RL; Borg CM; Coyle F; Prasad V; Shurey S; Ghatei MA; Patel AG; Bloom SR
    Ann Surg; 2006 Jan; 243(1):108-14. PubMed ID: 16371744
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Peripheral and central GLP-1 receptor populations mediate the anorectic effects of peripherally administered GLP-1 receptor agonists, liraglutide and exendin-4.
    Kanoski SE; Fortin SM; Arnold M; Grill HJ; Hayes MR
    Endocrinology; 2011 Aug; 152(8):3103-12. PubMed ID: 21693680
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Link Between Increased Satiety Gut Hormones and Reduced Food Reward After Gastric Bypass Surgery for Obesity.
    Goldstone AP; Miras AD; Scholtz S; Jackson S; Neff KJ; Pénicaud L; Geoghegan J; Chhina N; Durighel G; Bell JD; Meillon S; le Roux CW
    J Clin Endocrinol Metab; 2016 Feb; 101(2):599-609. PubMed ID: 26580235
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Do Gut Hormones Contribute to Weight Loss and Glycaemic Outcomes after Bariatric Surgery?
    Papamargaritis D; le Roux CW
    Nutrients; 2021 Feb; 13(3):. PubMed ID: 33652862
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Peptide YY3-36 and glucagon-like peptide-17-36 inhibit food intake additively.
    Neary NM; Small CJ; Druce MR; Park AJ; Ellis SM; Semjonous NM; Dakin CL; Filipsson K; Wang F; Kent AS; Frost GS; Ghatei MA; Bloom SR
    Endocrinology; 2005 Dec; 146(12):5120-7. PubMed ID: 16150917
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Changes in GI hormones and their effect on gastric emptying and transit times after Roux-en-Y gastric bypass in rat model.
    Suzuki S; Ramos EJ; Goncalves CG; Chen C; Meguid MM
    Surgery; 2005 Aug; 138(2):283-90. PubMed ID: 16153438
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Jejunal linoleic acid infusions require GLP-1 receptor signaling to inhibit food intake: implications for the effectiveness of Roux-en-Y gastric bypass.
    Dailey MJ; Moghadam AA; Moran TH
    Am J Physiol Endocrinol Metab; 2011 Dec; 301(6):E1184-90. PubMed ID: 21917638
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Peripheral exendin-4 and peptide YY(3-36) synergistically reduce food intake through different mechanisms in mice.
    Talsania T; Anini Y; Siu S; Drucker DJ; Brubaker PL
    Endocrinology; 2005 Sep; 146(9):3748-56. PubMed ID: 15932924
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Preoperative assessment of gut hormones does not correlate to weight loss after Roux-en-Y gastric bypass surgery.
    Werling M; Fändriks L; Vincent RP; Cross GF; le Roux CW; Olbers T
    Surg Obes Relat Dis; 2014; 10(5):822-8. PubMed ID: 25282191
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.